Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.3389/FIMMU.2025.1594723 | ||||
| Año | 2025 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Introduction Rheumatoid arthritis (RA) is an autoimmune disease influenced by genetic factors, particularly HLA-DRB1 alleles. The objective of this study was to characterize the distribution of HLA-DRB1 alleles in Chilean RA patients and healthy controls (HC) and evaluate associations with susceptibility or protection, autoantibody seropositivity, and disease activity.Methods We genotyped 367 RA patients and 623 HC for HLA-DRB1 using PCR-SSO. Then, we examined allele frequencies and distribution, including known RA risk alleles of the "Shared Epitope" (SE) of HLA-DRB1 and protective (PR) alleles, using the Chi-square or Fisher's exact tests. Odds ratios with 95% confidence intervals were calculated to measure the degree of association, and unpaired T-tests were used to compare continuous variables.Results The most frequent SE alleles among RA patients were *04:01 (16.1%), *04:04 (13.9%), and *14:02 (11.7%). SE alleles *04:01, *04:04, *04:05, *04:08, and *10:01, along with non-SE alleles *09:01 and *15:02, were associated with RA susceptibility. In addition, allele *14:02 showed an association with the presence of anti-cyclic citrullinated peptides (anti-CCP) antibodies. Meanwhile, PR alleles *11:01 (14.8%) and *16:02 (9.8%) were observed most frequently in HC and RA patients, respectively. PR alleles *11:01, *11:04, and *13:01, as well as the non-PR alleles *15:01, *04:07, *03:01, *07:01, and *08:02, were associated with protection from RA, and showed no significant associations with autoantibody seropositivity.Discussion This study provides a comprehensive overview of HLA-DRB1 allele distribution in the Chilean population, identifying both well-known and novel allele associations with RA susceptibility, protection, and disease activity.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Catalan, Diego | - |
Universidad de Chile - Chile
|
| 2 | SOTO-SAEZ, LILIAN ANDREA | Mujer |
Universidad de Chile - Chile
Hospital Clínico Universidad de Chile - Chile |
| 3 | Neira, Oscar | - |
Universidad de Chile - Chile
|
| 4 | Cuellar-Gutierrez, Maria C. | - |
Universidad de Chile - Chile
|
| 5 | Diaz, Roberto | Hombre |
Universidad Autónoma de Chile - Chile
Univ Santiago de Compostela USC - España Universidade de Santiago de Compostela - España |
| 6 | Aravena, Octavio | - |
Universidad de Chile - Chile
|
| 7 | Palou, Eduard | - |
HOSP CLIN BARCELONA - España
Hospital Clínic de Barcelona - España |
| 8 | Carrascal, Montserrat | - |
Spanish Natl Res Council - España
Institut d'Investigacions Biomèdiques August Pi i Sunyer - IDIBAPS - España |
| 9 | Aguillon, Juan C. | - |
Universidad de Chile - Chile
|
| 10 | Maggi, Jaxaira | - |
Spanish Natl Res Council - España
Institut d'Investigacions Biomèdiques August Pi i Sunyer - IDIBAPS - España |
| Fuente |
|---|
| Fondo Nacional de Desarrollo Científico y Tecnológico |
| Agencia Nacional de Investigacion y Desarrollo (ANID), Chile |
| Agencia Nacional de Investigación y Desarrollo |
| ANID-PFCHA/National Doctoral Scholarship 2018/Nz.ousco |
| Agradecimiento |
|---|
| The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by following projects: Fondef-IDeA ID15I10080, ID15I20080, ID18I10243, REDES 180028, Fondecyt 1181853, Fondecyt 1221611, Fondecyt 1220540 and Fondecyt 1240060, all granted by Agencia Nacional de Investigacion y Desarrollo (ANID), Chile. Doctoral training of JM was supported by ANID-PFCHA/National Doctoral Scholarship 2018/N & z.ousco;21181538. |
| The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by following projects: Fondef-IDeA ID15I10080, ID15I20080, ID18I10243, REDES 180028, Fondecyt 1181853, Fondecyt 1221611, Fondecyt 1220540 and Fondecyt 1240060, all granted by Agencia Nacional de Investigaci\u00F3n y Desarrollo (ANID), Chile. Doctoral training of JM was supported by ANID-PFCHA/National Doctoral Scholarship 2018/N&z.ousco;21181538. |